<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3703">
  <stage>Registered</stage>
  <submitdate>29/11/2012</submitdate>
  <approvaldate>29/11/2012</approvaldate>
  <nctid>NCT01744119</nctid>
  <trial_identification>
    <studytitle>Vascutek Anaconda Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance Registry</studytitle>
    <scientifictitle>Vascutek Anaconda Stent Graft System for Infra-Renal Abdominal Aortic Aneurysm Repair</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>ANA-PMS001</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Abdominal Aortic Aneurysm</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Vascutek Anaconda Stent Graft System

Abdominal Aortic Aneurysm - 


Treatment: devices: Vascutek Anaconda Stent Graft System


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Evaluation of graft performance - Data will be collected and analysed on system insertion and difficulty during deployment. Efficiency of the magnet system including magnet selection, ease of use and removal of magnet guidewire will also be evaluated.</outcome>
      <timepoint>60 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Graft patency - Data will be collected and analysed on endoleak exclusion and graft migration rates</outcome>
      <timepoint>60 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Exclusion of aneurysm</outcome>
      <timepoint>60 months</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Patient is implanted with Anaconda Stent Graft System</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Ruptured or symptomatic aneurysm

          -  Juxta or Suprarenal extension of aneurysm

          -  Clinically serious concomitant medical disease or infection

          -  Need to sacrifice both Internal Iliac Arteries due to aneurysmal dilatation

          -  Connective Tissue Disease (Marfan's Syndrome)

          -  ASA Rating of Grade IV or V

          -  Known allergy to Nitinol, Polyester or contrast medium

          -  Excessive tortuosity of access vessels (femoral or iliac arteries)

          -  Patients with aneurysm neck lengths of less than 15mm</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>318</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/05/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,VIC</recruitmentstate>
    <hospital>Dalcross Private Hospital - Killara</hospital>
    <hospital>Newcastle Private Medical Suites - Newcastle</hospital>
    <hospital>Westmead Hospital - Westmead</hospital>
    <hospital>The Austin Hospital - Heidelberg</hospital>
    <hospital>Geelong Regional Vascular Service - Geelong</hospital>
    <hospital>Royal Perth Hospital - Perth</hospital>
    <hospital>Hollywood, Royal Perth - Perth</hospital>
    <postcode>2071 - Killara</postcode>
    <postcode>NSW 2305 - Newcastle</postcode>
    <postcode>2145 - Westmead</postcode>
    <postcode>3084 - Heidelberg</postcode>
    <postcode>3220 - Geelong</postcode>
    <postcode>6000 - Perth</postcode>
    <postcode>WA 6000 - Perth</postcode>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Saint Doulchard</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Berlin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Dresden</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Munich</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Bologna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Naples</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Piacenza</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Roma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Hamilton</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Madrid</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Derby</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Glasgow</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Wishaw</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Vascutek Ltd.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this observational Post-Market Surveillance Registry is to gather post-market
      data on the performance of the CE marked Vascutek Anaconda Stent Graft System for the repair
      of Abdominal Aortic Aneurysms (AAA). The Study population consists of patients suitable for
      endovascular repair of AAA. Patients will be followed at 1, 3, 6, 12, 18, 24, 36, 48 and 60
      months post-implantation.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01744119</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>